Results 241 to 250 of about 6,012,951 (335)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Task-sharing echocardiographic screening for rheumatic heart disease in remote First Nations Australian communities: implementation evaluation from the NEARER SCAN study [PDF]

open access: green
Ben Jones   +38 more
openalex   +1 more source

Acute rheumatic fever and rheumatic heart disease in Latin America: a contemporary review of epidemiology

open access: gold
Antonio Mutarelli   +25 more
openalex   +1 more source

An echocardiographic appreciation of rheumatic heart disease: phenotypic variability of valvular involvement and its prognostic implications

open access: gold
Maria Carmo Pereira Nunes   +33 more
openalex   +1 more source

Is Less More? An Update on Aspirin for Cancer Prevention in Lynch Syndrome From the Cancer Prevention Programme—CaPP

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Aspirin has been used to treat pain and fever for 120 years. Its uses expanded into treating arthritis and prevention of thrombotic events. Its anti‐cancer role emerged with observational studies in the 1980's and subsequent cancer review in those treated with aspirin in cardiovascular trials.
John Burn, D. Timothy Bishop
wiley   +1 more source

Medical, interventional, and surgical management of rheumatic heart disease

open access: gold
Sheila Klassen   +27 more
openalex   +1 more source

Home - About - Disclaimer - Privacy